S. Potru, DO, FASAM, M. Sprintz, DO, DFASAM, A. M. Barreveld, MD, and L. Kohan, MD, “Buprenorphine: Not a silver bullet, and still controversial”, J of Opioid Management, vol. 17, no. 7, pp. 9–10, Aug. 2021.